Estados financieros detallados de Alterity Therapeutics Limited (ATHE): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $3.85, ATHE presenta beneficios negativos (P/E no significativo) y un ROE del -53.57%. La capitalización bursátil es de $65M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Ingresos | $132396 | $201174 | $108538 | 0 | $4.3M | $5.1M | $3.9M | $4.0M | $5.4M | 0 |
| Coste de Ventas | $21328 | $21799 | $29696 | $112427 | $360026 | $364665 | $285067 | $214304 | $127523 | $113010 |
| Beneficio Bruto | $111068 | $179375 | $78842 | -$112427 | $4.0M | $4.8M | $3.6M | $3.8M | $5.3M | -$113010 |
| I+D | $5.7M | $6.7M | $13.0M | $10.1M | $12.3M | $14.7M | $13.2M | $18.6M | $14.4M | $17.2M |
| Generales y Administrativos | $3.9M | $4.3M | $4.3M | $3.3M | $6.9M | $5.5M | $5.0M | $4.8M | $5.5M | $10.4M |
| Gastos Operativos | $6.8M | $11.1M | $12.5M | $10.1M | $19.2M | $20.3M | $18.2M | $23.4M | $19.9M | $27.7M |
| Beneficio Operativo | -$6.9M | -$7.8M | -$12.7M | -$10.4M | -$15.2M | -$15.5M | -$14.6M | -$19.6M | -$14.6M | -$27.8M |
| EBITDA | -$6.9M | -$11.4M | -$12.8M | -$13.3M | -$15.2M | -$17.4M | -$14.6M | -$19.6M | -$14.6M | -$27.7M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$7.5M | -$8.3M | -$12.3M | -$10.1M | -$15.3M | -$12.8M | -$13.7M | -$19.1M | -$12.1M | -$26.3M |
| Impuestos | $660213 | -$495440 | -$376031 | -$362188 | -$3.1M | $70008 | $104459 | $46088 | $68055 | -$3.4M |
| Beneficio Neto | -$7.5M | -$8.3M | -$12.0M | -$10.1M | -$15.3M | -$12.8M | -$13.8M | -$19.1M | -$12.1M | -$22.9M |
| BPA | $-8.46 | $-9.30 | $-11.64 | $-6.48 | $-5.40 | $-3.18 | $-3.42 | $-3.12 | $-1.14 | $-1.32 |
| BPA Diluido | $-8.46 | $-9.30 | $-11.64 | $-6.48 | $-5.40 | $-3.18 | $-3.42 | $-3.12 | $-1.14 | $-1.32 |
| Acciones en Circulación (Diluidas) | $889819 | $889819 | $1.0M | $1.5M | $2.8M | $4.0M | $4.0M | $6.1M | $10.7M | $17.5M |
Cuenta de Resultados (Trimestral)
| Año | 2024-Q4 | 2025-Q2 | 2025-Q4 | 2026-Q2 |
|---|
| Ingresos | $1.6M | $3.8M | 0 | 0 |
| Beneficio Bruto | $1.5M | $3.8M | -$56828 | -$58457 |
| Beneficio Operativo | -$7.5M | -$7.1M | -$12.8M | -$15.6M |
| EBITDA | -$7.5M | -$7.1M | -$12.8M | -$15.5M |
| Beneficio Neto | -$7.2M | -$5.0M | -$9.4M | -$14.0M |
| BPA | $-0.84 | $-0.42 | $-0.54 | $-0.78 |
| BPA Diluido | $-0.84 | $-0.42 | $-0.54 | $-0.78 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Caja y Equivalentes | $21.9M | $15.2M | $14.4M | $9.2M | $28.1M | $34.8M | $15.8M | $12.6M | $33.2M | $37.3M |
| Inversiones a Corto | $43988 | $9514 | 0 | 0 | 0 | 0 | 0 | 0 | $7.5M | 0 |
| Cuentas por Cobrar | $3.0M | $3.2M | $4.8M | $61321 | $4.1M | $4.7M | $8.6M | $4.0M | $3.9M | $7.7M |
| Inventario | $241625 | $256821 | $621737 | $567884 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $25.3M | $18.7M | $19.9M | $13.2M | $33.5M | $41.1M | $27.0M | $19.0M | $45.9M | $45.8M |
| Inmovilizado Material | $30815 | $71422 | $48748 | $71369 | $96808 | $218522 | $268863 | $186883 | $155174 | $190570 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $25.3M | $18.7M | $19.9M | $13.3M | $33.6M | $41.4M | $27.3M | $19.2M | $46.0M | $46.0M |
| Cuentas por Pagar | $65049 | $1.3M | $1.7M | $954033 | $1.4M | $2.6M | $1.7M | $581137 | $538276 | $1.1M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $55177 |
| Pasivos Corrientes | $1.6M | $2.6M | $3.3M | $2.7M | $3.1M | $5.8M | $4.4M | $5.4M | $3.5M | $3.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.6M | $2.6M | $3.4M | $2.8M | $3.1M | $5.9M | $4.5M | $5.4M | $3.6M | $3.3M |
| Reservas | -$122.6M | -$129.6M | -$141.2M | -$151.0M | -$169.7M | -$181.9M | -$195.1M | -$214.2M | -$225.9M | -$245.6M |
| Patrimonio Neto | $23.7M | $16.1M | $16.6M | $10.5M | $30.5M | $35.5M | $22.8M | $13.8M | $42.4M | $42.7M |
| Deuda Total | 0 | 0 | 0 | $33747 | $65649 | $117489 | $210384 | $159045 | $155457 | $193475 |
| Deuda Neta | -$21.9M | -$15.2M | -$14.4M | -$9.2M | -$28.0M | -$34.7M | -$15.6M | -$12.5M | -$40.5M | -$37.1M |
| Capital Circulante | $23.7M | $16.0M | $16.5M | $10.5M | $30.4M | $35.3M | $22.7M | $13.7M | $42.3M | $42.7M |
Balance (Trimestral)
| Año | 2024-Q4 | 2025-Q2 | 2025-Q4 | 2026-Q2 |
|---|
| Caja y Equivalentes | $4.5M | $33.2M | $49.2M | $37.3M |
| Activos Totales | $10.5M | $46.0M | $56.9M | $46.0M |
| Pasivos Totales | $2.8M | $3.6M | $2.6M | $3.3M |
| Patrimonio Neto | $7.8M | $42.4M | $54.2M | $42.7M |
| Deuda Total | $105831 | $155457 | $98350 | $193475 |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Beneficio Neto | -$7.5M | -$8.3M | -$12.3M | -$10.1M | -$15.3M | -$12.8M | -$13.8M | -$19.1M | -$12.1M | -$22.9M |
| Amortizaciones | $21328 | $21799 | $29696 | $112427 | $75369 | $54214 | $102263 | $147529 | $139715 | $113010 |
| Compensación en Acciones | $24460 | $764539 | $89138 | -$12016 | $1.9M | $1.5M | $966571 | $881950 | $979920 | 0 |
| Cambio en Capital Circulante | $975189 | $956094 | -$1.3M | $791128 | -$4.2M | -$447684 | -$3.9M | $5.7M | -$613678 | -$3.6M |
| Flujo de Caja Operativo | -$5.9M | -$6.2M | -$14.0M | -$9.4M | -$17.3M | -$12.3M | -$20.0M | -$12.6M | -$11.5M | -$22.0M |
| Inversiones (CapEx) | -$27918 | -$62405 | -$7022 | -$16744 | -$10472 | -$89147 | -$7311 | -$5722 | $3 | $22.0M |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$5.9M | -$6.3M | -$14.0M | -$9.4M | -$17.3M | -$12.4M | -$20.0M | -$12.6M | -$11.5M | 0 |
Flujo de Caja (Trimestral)
| Año | 2024-Q4 | 2025-Q2 | 2025-Q4 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$8.4M | -$2.4M | -$10.4M | -$12.8M |
| Inversiones (CapEx) | -$2 | 0 | $10.4M | $12.8M |
| Flujo de Caja Libre | -$8.4M | -$2.4M | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.1M | -$141341 | 0 | 0 |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Crecimiento Ingresos (anual) | | +51.9% | -46.0% | -100.0% | | +18.1% | -23.6% | +2.6% | +35.3% | -100.0% |
| Crecimiento Beneficio Neto (anual) | | -9.6% | -44.7% | +15.9% | -52.2% | +16.1% | -7.5% | -38.5% | +36.5% | -88.4% |
| Crecimiento BPA (anual) | | -9.9% | -25.2% | +44.3% | +16.7% | +41.1% | -7.5% | +8.8% | +63.5% | -15.8% |
| Cambio en Acciones (anual) | | +0.0% | +15.3% | +45.3% | +89.6% | +41.8% | +0.9% | +50.3% | +75.3% | +64.5% |
| Crecimiento FCF (anual) | | -7.0% | -121.3% | +32.3% | -83.5% | +28.3% | -61.3% | +37.1% | +9.2% | +100.0% |
| Margen Bruto | 83.9% | 89.2% | 72.6% | | 91.7% | 92.9% | 92.7% | 94.7% | 97.7% | |
| Margen Operativo | -5197.9% | -3862.5% | -11713.7% | | -349.8% | -302.6% | -373.7% | -487.7% | -268.0% | |
| Margen EBITDA | -5181.8% | -5651.7% | -11761.5% | | -349.3% | -339.5% | -372.8% | -486.9% | -269.0% | |
| Margen Neto | -5696.6% | -4108.8% | -11020.8% | | -352.8% | -250.7% | -352.5% | -475.8% | -223.4% | |
| Margen FCF | -4451.0% | -3135.4% | -12863.6% | | -399.6% | -242.5% | -511.8% | -313.8% | -210.5% | |
| Tasa Impositiva Efectiva | -8.8% | 6.0% | 3.0% | 3.6% | 20.1% | -0.5% | -0.8% | -0.2% | -0.6% | 13.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| FCF por Acción | $-6.62 | $-7.09 | $-13.60 | $-6.33 | $-6.13 | $-3.10 | $-4.95 | $-2.07 | $-1.07 | $0.00 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $889819 | $888788 | $1.0M | $1.5M | $2.8M | $4.0M | $4.0M | $6.1M | $10.7M | $17.5M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -53.57% |
| Rentabilidad sobre capital invertido | -56.35% |
| Rentabilidad sobre activos | -49.74% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 14.52 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| P/E | -3.52 | -2.74 | -1.58 | -2.66 | -3.21 | -2.78 | -1.22 | -0.87 | -5.45 | -5.88 |
| P/VC | 1.12 | 1.41 | 1.14 | 2.44 | 1.61 | 1.00 | 0.74 | 1.19 | 1.56 | 3.19 |
| P/V | 199.87 | 112.74 | 173.72 | 0.00 | 11.29 | 6.91 | 4.33 | 4.09 | 12.18 | 0.00 |
| Margen Bruto | 83.9% | 89.2% | 72.6% | 0.0% | 91.7% | 92.9% | 92.7% | 94.7% | 97.7% | 0.0% |
| Margen Operativo | -5197.9% | -3862.5% | -11713.7% | 0.0% | -349.8% | -302.6% | -373.7% | -487.7% | -268.0% | 0.0% |
| Margen Neto | -5696.6% | -4108.8% | -11020.8% | 0.0% | -352.8% | -250.7% | -352.5% | -475.8% | -223.4% | 0.0% |